way 123398 has been researched along with Hyperplasia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arcangeli, A; Becchetti, A; Borrani, E; Borri, P; Buccoliero, AM; Cherubini, A; Crociani, O; Fontana, L; Giachi, M; Noci, I; Olivotto, M; Paglierani, M; Rosati, B; Taddei, GL; Wanke, E | 1 |
1 other study(ies) available for way 123398 and Hyperplasia
| Article | Year |
|---|---|
HERG potassium channels are more frequently expressed in human endometrial cancer as compared to non-cancerous endometrium.
Topics: Aged; Aged, 80 and over; Benzimidazoles; Blotting, Western; Cation Transport Proteins; DNA-Binding Proteins; Electrophysiology; Endometrial Neoplasms; Endometrium; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Female; Gene Expression Regulation; Humans; Hyperplasia; Immunohistochemistry; Membrane Potentials; Middle Aged; Potassium Channels; Potassium Channels, Voltage-Gated; Reverse Transcriptase Polymerase Chain Reaction; RNA; Sulfanilamides; Trans-Activators; Transcriptional Regulator ERG; Tumor Cells, Cultured | 2000 |